Global and Regional Infection Control Market

Infection Control Comprehensive Study by Type (Hand Disinfectants, Skin Disinfectants, Instrument Disinfectants, Surface Disinfectants), Application (Hospitals & Clinics, Life Sciences Industry, Medical Device Companies, Pharmaceutical Companies, Food Industry), Sterilization (Steam, Hydrogen Peroxide, Radiation, Indicators, Services), Disinfection (Disinfectant, Wipes, Sprays, Liquids, UV, Wraps), End User (Hospitals, Medical Device Companies, Pharmaceutical Companies, Life Sciences Industry, Food Industry) Players and Region - Global Market Outlook to 2030

Infection Control Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 6.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Infection Control
Infection Control refer to prevention from healthcare related infections. Rising healthcare infrastructure in developing economies is the major factor growing the industry. . In addition development in e-beam sterilization, food sterilization, growing demand among pharmaceutical and medical device manufacturers, technologically advanced products are projected to drive the sales over forecast period.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR6.3%


The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Infection Control market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Steris (United Kingdom), Getinge (Sweden), Ecolab (United States), 3M (United States), Advanced Sterilization Products (United States), Cantel Medical (United States), Sotera Health (United States), MMM Group (Germany) and Matachana (Spain) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Belimed AG (Switzerland), Pal International (United Kingdom), Halyard Health (United States), Metrex Research (United States) and Reckitt Benckiser (United Kingdom).

Segmentation Overview
AMA Research has segmented the market of Global Infection Control market by Type (Hand Disinfectants, Skin Disinfectants, Instrument Disinfectants and Surface Disinfectants), Application (Hospitals & Clinics, Life Sciences Industry, Medical Device Companies, Pharmaceutical Companies and Food Industry) and Region.



On the basis of geography, the market of Infection Control has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Sterilization, the sub-segment i.e. Steam will boost the Infection Control market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Disinfection, the sub-segment i.e. Disinfectant will boost the Infection Control market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Infection Control market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Emphasis on Food Disinfection

Market Growth Drivers:
Increasing Number of Surgeries and Chronic Diseases and Growing Hospital Acquired Infections

Challenges:
Disinfection of Advanced Medical Instruments

Restraints:
Stringent Government Regulations and Trustworthiness of Reprocessed Instruments

Opportunities:
Expansion of Healthcare Infrastructure in Emerging Economies and Adoption of E-Beam Sterilization

Market Leaders and their expansionary development strategies
In June 2023, GAMA Healthcare partnered with ACIPC to bring to life the IPC Tour in Brisbane, Sydney, Melbourne and Perth. We welcomed more than 330 delegates across the events who enjoyed the opportunity to discuss local challenges while networking with their peers and listening to national and international speakers.
In December 2023, The Association for Professionals in Infection Control and Epidemiology (APIC) today announced the launch of a tool intended to help Infection Prevention and Control leaders determine the right staffing levels for their programs and improve efforts to prevent healthcare-associated infections. The APIC IP Staffing Calculator was developed following a literature review of existing infection preventionist (IP) staffing models as well as surveys from multiple participant facilities.


Key Target Audience
Healthcare providers (hospitals and clinics), Contract sterilization service providers, Sterilization and disinfection service providers, Medical device companies, Pharmaceutical and biotechnology companies, Food and beverage companies, Clinical and Diagnostic Labs, Contract research organizations (CROs), Hospitals & Clinics, Life Sciences Industry, Medical Device Companies, Pharmaceutical Companies, Food Industry, Regulatory bodies, Research and consulting firms and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Hand Disinfectants
  • Skin Disinfectants
  • Instrument Disinfectants
  • Surface Disinfectants
By Application
  • Hospitals & Clinics
  • Life Sciences Industry
  • Medical Device Companies
  • Pharmaceutical Companies
  • Food Industry
By Sterilization
  • Steam
  • Hydrogen Peroxide
  • Radiation
  • Indicators
  • Services

By Disinfection
  • Disinfectant
  • Wipes
  • Sprays
  • Liquids
  • UV
  • Wraps

By End User
  • Hospitals
  • Medical Device Companies
  • Pharmaceutical Companies
  • Life Sciences Industry
  • Food Industry

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Surgeries and Chronic Diseases
      • 3.2.2. Growing Hospital Acquired Infections
    • 3.3. Market Challenges
      • 3.3.1. Disinfection of Advanced Medical Instruments
    • 3.4. Market Trends
      • 3.4.1. Growing Emphasis on Food Disinfection
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Infection Control, by Type, Application, Sterilization, Disinfection, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Infection Control (Value)
      • 5.2.1. Global Infection Control by: Type (Value)
        • 5.2.1.1. Hand Disinfectants
        • 5.2.1.2. Skin Disinfectants
        • 5.2.1.3. Instrument Disinfectants
        • 5.2.1.4. Surface Disinfectants
      • 5.2.2. Global Infection Control by: Application (Value)
        • 5.2.2.1. Hospitals & Clinics
        • 5.2.2.2. Life Sciences Industry
        • 5.2.2.3. Medical Device Companies
        • 5.2.2.4. Pharmaceutical Companies
        • 5.2.2.5. Food Industry
      • 5.2.3. Global Infection Control by: Sterilization (Value)
        • 5.2.3.1. Steam
        • 5.2.3.2. Hydrogen Peroxide
        • 5.2.3.3. Radiation
        • 5.2.3.4. Indicators
        • 5.2.3.5. Services
      • 5.2.4. Global Infection Control by: Disinfection (Value)
        • 5.2.4.1. Disinfectant
        • 5.2.4.2. Wipes
        • 5.2.4.3. Sprays
        • 5.2.4.4. Liquids
        • 5.2.4.5. UV
        • 5.2.4.6. Wraps
      • 5.2.5. Global Infection Control by: End User (Value)
        • 5.2.5.1. Hospitals
        • 5.2.5.2. Medical Device Companies
        • 5.2.5.3. Pharmaceutical Companies
        • 5.2.5.4. Life Sciences Industry
        • 5.2.5.5. Food Industry
      • 5.2.6. Global Infection Control Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Infection Control: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Steris (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Getinge (Sweden)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ecolab (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. 3M (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Advanced Sterilization Products (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cantel Medical (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sotera Health (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. MMM Group (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Matachana (Spain)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Infection Control Sale, by Type, Application, Sterilization, Disinfection, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Infection Control (Value)
      • 7.2.1. Global Infection Control by: Type (Value)
        • 7.2.1.1. Hand Disinfectants
        • 7.2.1.2. Skin Disinfectants
        • 7.2.1.3. Instrument Disinfectants
        • 7.2.1.4. Surface Disinfectants
      • 7.2.2. Global Infection Control by: Application (Value)
        • 7.2.2.1. Hospitals & Clinics
        • 7.2.2.2. Life Sciences Industry
        • 7.2.2.3. Medical Device Companies
        • 7.2.2.4. Pharmaceutical Companies
        • 7.2.2.5. Food Industry
      • 7.2.3. Global Infection Control by: Sterilization (Value)
        • 7.2.3.1. Steam
        • 7.2.3.2. Hydrogen Peroxide
        • 7.2.3.3. Radiation
        • 7.2.3.4. Indicators
        • 7.2.3.5. Services
      • 7.2.4. Global Infection Control by: Disinfection (Value)
        • 7.2.4.1. Disinfectant
        • 7.2.4.2. Wipes
        • 7.2.4.3. Sprays
        • 7.2.4.4. Liquids
        • 7.2.4.5. UV
        • 7.2.4.6. Wraps
      • 7.2.5. Global Infection Control by: End User (Value)
        • 7.2.5.1. Hospitals
        • 7.2.5.2. Medical Device Companies
        • 7.2.5.3. Pharmaceutical Companies
        • 7.2.5.4. Life Sciences Industry
        • 7.2.5.5. Food Industry
      • 7.2.6. Global Infection Control Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Infection Control: by Type(USD Million)
  • Table 2. Infection Control Hand Disinfectants , by Region USD Million (2018-2023)
  • Table 3. Infection Control Skin Disinfectants , by Region USD Million (2018-2023)
  • Table 4. Infection Control Instrument Disinfectants , by Region USD Million (2018-2023)
  • Table 5. Infection Control Surface Disinfectants , by Region USD Million (2018-2023)
  • Table 6. Infection Control: by Application(USD Million)
  • Table 7. Infection Control Hospitals & Clinics , by Region USD Million (2018-2023)
  • Table 8. Infection Control Life Sciences Industry , by Region USD Million (2018-2023)
  • Table 9. Infection Control Medical Device Companies , by Region USD Million (2018-2023)
  • Table 10. Infection Control Pharmaceutical Companies , by Region USD Million (2018-2023)
  • Table 11. Infection Control Food Industry , by Region USD Million (2018-2023)
  • Table 12. Infection Control: by Sterilization(USD Million)
  • Table 13. Infection Control Steam , by Region USD Million (2018-2023)
  • Table 14. Infection Control Hydrogen Peroxide , by Region USD Million (2018-2023)
  • Table 15. Infection Control Radiation , by Region USD Million (2018-2023)
  • Table 16. Infection Control Indicators , by Region USD Million (2018-2023)
  • Table 17. Infection Control Services , by Region USD Million (2018-2023)
  • Table 18. Infection Control: by Disinfection(USD Million)
  • Table 19. Infection Control Disinfectant , by Region USD Million (2018-2023)
  • Table 20. Infection Control Wipes , by Region USD Million (2018-2023)
  • Table 21. Infection Control Sprays , by Region USD Million (2018-2023)
  • Table 22. Infection Control Liquids , by Region USD Million (2018-2023)
  • Table 23. Infection Control UV , by Region USD Million (2018-2023)
  • Table 24. Infection Control Wraps , by Region USD Million (2018-2023)
  • Table 25. Infection Control: by End User(USD Million)
  • Table 26. Infection Control Hospitals , by Region USD Million (2018-2023)
  • Table 27. Infection Control Medical Device Companies , by Region USD Million (2018-2023)
  • Table 28. Infection Control Pharmaceutical Companies , by Region USD Million (2018-2023)
  • Table 29. Infection Control Life Sciences Industry , by Region USD Million (2018-2023)
  • Table 30. Infection Control Food Industry , by Region USD Million (2018-2023)
  • Table 31. South America Infection Control, by Country USD Million (2018-2023)
  • Table 32. South America Infection Control, by Type USD Million (2018-2023)
  • Table 33. South America Infection Control, by Application USD Million (2018-2023)
  • Table 34. South America Infection Control, by Sterilization USD Million (2018-2023)
  • Table 35. South America Infection Control, by Disinfection USD Million (2018-2023)
  • Table 36. South America Infection Control, by End User USD Million (2018-2023)
  • Table 37. Brazil Infection Control, by Type USD Million (2018-2023)
  • Table 38. Brazil Infection Control, by Application USD Million (2018-2023)
  • Table 39. Brazil Infection Control, by Sterilization USD Million (2018-2023)
  • Table 40. Brazil Infection Control, by Disinfection USD Million (2018-2023)
  • Table 41. Brazil Infection Control, by End User USD Million (2018-2023)
  • Table 42. Argentina Infection Control, by Type USD Million (2018-2023)
  • Table 43. Argentina Infection Control, by Application USD Million (2018-2023)
  • Table 44. Argentina Infection Control, by Sterilization USD Million (2018-2023)
  • Table 45. Argentina Infection Control, by Disinfection USD Million (2018-2023)
  • Table 46. Argentina Infection Control, by End User USD Million (2018-2023)
  • Table 47. Rest of South America Infection Control, by Type USD Million (2018-2023)
  • Table 48. Rest of South America Infection Control, by Application USD Million (2018-2023)
  • Table 49. Rest of South America Infection Control, by Sterilization USD Million (2018-2023)
  • Table 50. Rest of South America Infection Control, by Disinfection USD Million (2018-2023)
  • Table 51. Rest of South America Infection Control, by End User USD Million (2018-2023)
  • Table 52. Asia Pacific Infection Control, by Country USD Million (2018-2023)
  • Table 53. Asia Pacific Infection Control, by Type USD Million (2018-2023)
  • Table 54. Asia Pacific Infection Control, by Application USD Million (2018-2023)
  • Table 55. Asia Pacific Infection Control, by Sterilization USD Million (2018-2023)
  • Table 56. Asia Pacific Infection Control, by Disinfection USD Million (2018-2023)
  • Table 57. Asia Pacific Infection Control, by End User USD Million (2018-2023)
  • Table 58. China Infection Control, by Type USD Million (2018-2023)
  • Table 59. China Infection Control, by Application USD Million (2018-2023)
  • Table 60. China Infection Control, by Sterilization USD Million (2018-2023)
  • Table 61. China Infection Control, by Disinfection USD Million (2018-2023)
  • Table 62. China Infection Control, by End User USD Million (2018-2023)
  • Table 63. Japan Infection Control, by Type USD Million (2018-2023)
  • Table 64. Japan Infection Control, by Application USD Million (2018-2023)
  • Table 65. Japan Infection Control, by Sterilization USD Million (2018-2023)
  • Table 66. Japan Infection Control, by Disinfection USD Million (2018-2023)
  • Table 67. Japan Infection Control, by End User USD Million (2018-2023)
  • Table 68. India Infection Control, by Type USD Million (2018-2023)
  • Table 69. India Infection Control, by Application USD Million (2018-2023)
  • Table 70. India Infection Control, by Sterilization USD Million (2018-2023)
  • Table 71. India Infection Control, by Disinfection USD Million (2018-2023)
  • Table 72. India Infection Control, by End User USD Million (2018-2023)
  • Table 73. South Korea Infection Control, by Type USD Million (2018-2023)
  • Table 74. South Korea Infection Control, by Application USD Million (2018-2023)
  • Table 75. South Korea Infection Control, by Sterilization USD Million (2018-2023)
  • Table 76. South Korea Infection Control, by Disinfection USD Million (2018-2023)
  • Table 77. South Korea Infection Control, by End User USD Million (2018-2023)
  • Table 78. Taiwan Infection Control, by Type USD Million (2018-2023)
  • Table 79. Taiwan Infection Control, by Application USD Million (2018-2023)
  • Table 80. Taiwan Infection Control, by Sterilization USD Million (2018-2023)
  • Table 81. Taiwan Infection Control, by Disinfection USD Million (2018-2023)
  • Table 82. Taiwan Infection Control, by End User USD Million (2018-2023)
  • Table 83. Australia Infection Control, by Type USD Million (2018-2023)
  • Table 84. Australia Infection Control, by Application USD Million (2018-2023)
  • Table 85. Australia Infection Control, by Sterilization USD Million (2018-2023)
  • Table 86. Australia Infection Control, by Disinfection USD Million (2018-2023)
  • Table 87. Australia Infection Control, by End User USD Million (2018-2023)
  • Table 88. Rest of Asia-Pacific Infection Control, by Type USD Million (2018-2023)
  • Table 89. Rest of Asia-Pacific Infection Control, by Application USD Million (2018-2023)
  • Table 90. Rest of Asia-Pacific Infection Control, by Sterilization USD Million (2018-2023)
  • Table 91. Rest of Asia-Pacific Infection Control, by Disinfection USD Million (2018-2023)
  • Table 92. Rest of Asia-Pacific Infection Control, by End User USD Million (2018-2023)
  • Table 93. Europe Infection Control, by Country USD Million (2018-2023)
  • Table 94. Europe Infection Control, by Type USD Million (2018-2023)
  • Table 95. Europe Infection Control, by Application USD Million (2018-2023)
  • Table 96. Europe Infection Control, by Sterilization USD Million (2018-2023)
  • Table 97. Europe Infection Control, by Disinfection USD Million (2018-2023)
  • Table 98. Europe Infection Control, by End User USD Million (2018-2023)
  • Table 99. Germany Infection Control, by Type USD Million (2018-2023)
  • Table 100. Germany Infection Control, by Application USD Million (2018-2023)
  • Table 101. Germany Infection Control, by Sterilization USD Million (2018-2023)
  • Table 102. Germany Infection Control, by Disinfection USD Million (2018-2023)
  • Table 103. Germany Infection Control, by End User USD Million (2018-2023)
  • Table 104. France Infection Control, by Type USD Million (2018-2023)
  • Table 105. France Infection Control, by Application USD Million (2018-2023)
  • Table 106. France Infection Control, by Sterilization USD Million (2018-2023)
  • Table 107. France Infection Control, by Disinfection USD Million (2018-2023)
  • Table 108. France Infection Control, by End User USD Million (2018-2023)
  • Table 109. Italy Infection Control, by Type USD Million (2018-2023)
  • Table 110. Italy Infection Control, by Application USD Million (2018-2023)
  • Table 111. Italy Infection Control, by Sterilization USD Million (2018-2023)
  • Table 112. Italy Infection Control, by Disinfection USD Million (2018-2023)
  • Table 113. Italy Infection Control, by End User USD Million (2018-2023)
  • Table 114. United Kingdom Infection Control, by Type USD Million (2018-2023)
  • Table 115. United Kingdom Infection Control, by Application USD Million (2018-2023)
  • Table 116. United Kingdom Infection Control, by Sterilization USD Million (2018-2023)
  • Table 117. United Kingdom Infection Control, by Disinfection USD Million (2018-2023)
  • Table 118. United Kingdom Infection Control, by End User USD Million (2018-2023)
  • Table 119. Netherlands Infection Control, by Type USD Million (2018-2023)
  • Table 120. Netherlands Infection Control, by Application USD Million (2018-2023)
  • Table 121. Netherlands Infection Control, by Sterilization USD Million (2018-2023)
  • Table 122. Netherlands Infection Control, by Disinfection USD Million (2018-2023)
  • Table 123. Netherlands Infection Control, by End User USD Million (2018-2023)
  • Table 124. Rest of Europe Infection Control, by Type USD Million (2018-2023)
  • Table 125. Rest of Europe Infection Control, by Application USD Million (2018-2023)
  • Table 126. Rest of Europe Infection Control, by Sterilization USD Million (2018-2023)
  • Table 127. Rest of Europe Infection Control, by Disinfection USD Million (2018-2023)
  • Table 128. Rest of Europe Infection Control, by End User USD Million (2018-2023)
  • Table 129. MEA Infection Control, by Country USD Million (2018-2023)
  • Table 130. MEA Infection Control, by Type USD Million (2018-2023)
  • Table 131. MEA Infection Control, by Application USD Million (2018-2023)
  • Table 132. MEA Infection Control, by Sterilization USD Million (2018-2023)
  • Table 133. MEA Infection Control, by Disinfection USD Million (2018-2023)
  • Table 134. MEA Infection Control, by End User USD Million (2018-2023)
  • Table 135. Middle East Infection Control, by Type USD Million (2018-2023)
  • Table 136. Middle East Infection Control, by Application USD Million (2018-2023)
  • Table 137. Middle East Infection Control, by Sterilization USD Million (2018-2023)
  • Table 138. Middle East Infection Control, by Disinfection USD Million (2018-2023)
  • Table 139. Middle East Infection Control, by End User USD Million (2018-2023)
  • Table 140. Africa Infection Control, by Type USD Million (2018-2023)
  • Table 141. Africa Infection Control, by Application USD Million (2018-2023)
  • Table 142. Africa Infection Control, by Sterilization USD Million (2018-2023)
  • Table 143. Africa Infection Control, by Disinfection USD Million (2018-2023)
  • Table 144. Africa Infection Control, by End User USD Million (2018-2023)
  • Table 145. North America Infection Control, by Country USD Million (2018-2023)
  • Table 146. North America Infection Control, by Type USD Million (2018-2023)
  • Table 147. North America Infection Control, by Application USD Million (2018-2023)
  • Table 148. North America Infection Control, by Sterilization USD Million (2018-2023)
  • Table 149. North America Infection Control, by Disinfection USD Million (2018-2023)
  • Table 150. North America Infection Control, by End User USD Million (2018-2023)
  • Table 151. United States Infection Control, by Type USD Million (2018-2023)
  • Table 152. United States Infection Control, by Application USD Million (2018-2023)
  • Table 153. United States Infection Control, by Sterilization USD Million (2018-2023)
  • Table 154. United States Infection Control, by Disinfection USD Million (2018-2023)
  • Table 155. United States Infection Control, by End User USD Million (2018-2023)
  • Table 156. Canada Infection Control, by Type USD Million (2018-2023)
  • Table 157. Canada Infection Control, by Application USD Million (2018-2023)
  • Table 158. Canada Infection Control, by Sterilization USD Million (2018-2023)
  • Table 159. Canada Infection Control, by Disinfection USD Million (2018-2023)
  • Table 160. Canada Infection Control, by End User USD Million (2018-2023)
  • Table 161. Mexico Infection Control, by Type USD Million (2018-2023)
  • Table 162. Mexico Infection Control, by Application USD Million (2018-2023)
  • Table 163. Mexico Infection Control, by Sterilization USD Million (2018-2023)
  • Table 164. Mexico Infection Control, by Disinfection USD Million (2018-2023)
  • Table 165. Mexico Infection Control, by End User USD Million (2018-2023)
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Company Basic Information, Sales Area and Its Competitors
  • Table 172. Company Basic Information, Sales Area and Its Competitors
  • Table 173. Company Basic Information, Sales Area and Its Competitors
  • Table 174. Company Basic Information, Sales Area and Its Competitors
  • Table 175. Infection Control: by Type(USD Million)
  • Table 176. Infection Control Hand Disinfectants , by Region USD Million (2025-2030)
  • Table 177. Infection Control Skin Disinfectants , by Region USD Million (2025-2030)
  • Table 178. Infection Control Instrument Disinfectants , by Region USD Million (2025-2030)
  • Table 179. Infection Control Surface Disinfectants , by Region USD Million (2025-2030)
  • Table 180. Infection Control: by Application(USD Million)
  • Table 181. Infection Control Hospitals & Clinics , by Region USD Million (2025-2030)
  • Table 182. Infection Control Life Sciences Industry , by Region USD Million (2025-2030)
  • Table 183. Infection Control Medical Device Companies , by Region USD Million (2025-2030)
  • Table 184. Infection Control Pharmaceutical Companies , by Region USD Million (2025-2030)
  • Table 185. Infection Control Food Industry , by Region USD Million (2025-2030)
  • Table 186. Infection Control: by Sterilization(USD Million)
  • Table 187. Infection Control Steam , by Region USD Million (2025-2030)
  • Table 188. Infection Control Hydrogen Peroxide , by Region USD Million (2025-2030)
  • Table 189. Infection Control Radiation , by Region USD Million (2025-2030)
  • Table 190. Infection Control Indicators , by Region USD Million (2025-2030)
  • Table 191. Infection Control Services , by Region USD Million (2025-2030)
  • Table 192. Infection Control: by Disinfection(USD Million)
  • Table 193. Infection Control Disinfectant , by Region USD Million (2025-2030)
  • Table 194. Infection Control Wipes , by Region USD Million (2025-2030)
  • Table 195. Infection Control Sprays , by Region USD Million (2025-2030)
  • Table 196. Infection Control Liquids , by Region USD Million (2025-2030)
  • Table 197. Infection Control UV , by Region USD Million (2025-2030)
  • Table 198. Infection Control Wraps , by Region USD Million (2025-2030)
  • Table 199. Infection Control: by End User(USD Million)
  • Table 200. Infection Control Hospitals , by Region USD Million (2025-2030)
  • Table 201. Infection Control Medical Device Companies , by Region USD Million (2025-2030)
  • Table 202. Infection Control Pharmaceutical Companies , by Region USD Million (2025-2030)
  • Table 203. Infection Control Life Sciences Industry , by Region USD Million (2025-2030)
  • Table 204. Infection Control Food Industry , by Region USD Million (2025-2030)
  • Table 205. South America Infection Control, by Country USD Million (2025-2030)
  • Table 206. South America Infection Control, by Type USD Million (2025-2030)
  • Table 207. South America Infection Control, by Application USD Million (2025-2030)
  • Table 208. South America Infection Control, by Sterilization USD Million (2025-2030)
  • Table 209. South America Infection Control, by Disinfection USD Million (2025-2030)
  • Table 210. South America Infection Control, by End User USD Million (2025-2030)
  • Table 211. Brazil Infection Control, by Type USD Million (2025-2030)
  • Table 212. Brazil Infection Control, by Application USD Million (2025-2030)
  • Table 213. Brazil Infection Control, by Sterilization USD Million (2025-2030)
  • Table 214. Brazil Infection Control, by Disinfection USD Million (2025-2030)
  • Table 215. Brazil Infection Control, by End User USD Million (2025-2030)
  • Table 216. Argentina Infection Control, by Type USD Million (2025-2030)
  • Table 217. Argentina Infection Control, by Application USD Million (2025-2030)
  • Table 218. Argentina Infection Control, by Sterilization USD Million (2025-2030)
  • Table 219. Argentina Infection Control, by Disinfection USD Million (2025-2030)
  • Table 220. Argentina Infection Control, by End User USD Million (2025-2030)
  • Table 221. Rest of South America Infection Control, by Type USD Million (2025-2030)
  • Table 222. Rest of South America Infection Control, by Application USD Million (2025-2030)
  • Table 223. Rest of South America Infection Control, by Sterilization USD Million (2025-2030)
  • Table 224. Rest of South America Infection Control, by Disinfection USD Million (2025-2030)
  • Table 225. Rest of South America Infection Control, by End User USD Million (2025-2030)
  • Table 226. Asia Pacific Infection Control, by Country USD Million (2025-2030)
  • Table 227. Asia Pacific Infection Control, by Type USD Million (2025-2030)
  • Table 228. Asia Pacific Infection Control, by Application USD Million (2025-2030)
  • Table 229. Asia Pacific Infection Control, by Sterilization USD Million (2025-2030)
  • Table 230. Asia Pacific Infection Control, by Disinfection USD Million (2025-2030)
  • Table 231. Asia Pacific Infection Control, by End User USD Million (2025-2030)
  • Table 232. China Infection Control, by Type USD Million (2025-2030)
  • Table 233. China Infection Control, by Application USD Million (2025-2030)
  • Table 234. China Infection Control, by Sterilization USD Million (2025-2030)
  • Table 235. China Infection Control, by Disinfection USD Million (2025-2030)
  • Table 236. China Infection Control, by End User USD Million (2025-2030)
  • Table 237. Japan Infection Control, by Type USD Million (2025-2030)
  • Table 238. Japan Infection Control, by Application USD Million (2025-2030)
  • Table 239. Japan Infection Control, by Sterilization USD Million (2025-2030)
  • Table 240. Japan Infection Control, by Disinfection USD Million (2025-2030)
  • Table 241. Japan Infection Control, by End User USD Million (2025-2030)
  • Table 242. India Infection Control, by Type USD Million (2025-2030)
  • Table 243. India Infection Control, by Application USD Million (2025-2030)
  • Table 244. India Infection Control, by Sterilization USD Million (2025-2030)
  • Table 245. India Infection Control, by Disinfection USD Million (2025-2030)
  • Table 246. India Infection Control, by End User USD Million (2025-2030)
  • Table 247. South Korea Infection Control, by Type USD Million (2025-2030)
  • Table 248. South Korea Infection Control, by Application USD Million (2025-2030)
  • Table 249. South Korea Infection Control, by Sterilization USD Million (2025-2030)
  • Table 250. South Korea Infection Control, by Disinfection USD Million (2025-2030)
  • Table 251. South Korea Infection Control, by End User USD Million (2025-2030)
  • Table 252. Taiwan Infection Control, by Type USD Million (2025-2030)
  • Table 253. Taiwan Infection Control, by Application USD Million (2025-2030)
  • Table 254. Taiwan Infection Control, by Sterilization USD Million (2025-2030)
  • Table 255. Taiwan Infection Control, by Disinfection USD Million (2025-2030)
  • Table 256. Taiwan Infection Control, by End User USD Million (2025-2030)
  • Table 257. Australia Infection Control, by Type USD Million (2025-2030)
  • Table 258. Australia Infection Control, by Application USD Million (2025-2030)
  • Table 259. Australia Infection Control, by Sterilization USD Million (2025-2030)
  • Table 260. Australia Infection Control, by Disinfection USD Million (2025-2030)
  • Table 261. Australia Infection Control, by End User USD Million (2025-2030)
  • Table 262. Rest of Asia-Pacific Infection Control, by Type USD Million (2025-2030)
  • Table 263. Rest of Asia-Pacific Infection Control, by Application USD Million (2025-2030)
  • Table 264. Rest of Asia-Pacific Infection Control, by Sterilization USD Million (2025-2030)
  • Table 265. Rest of Asia-Pacific Infection Control, by Disinfection USD Million (2025-2030)
  • Table 266. Rest of Asia-Pacific Infection Control, by End User USD Million (2025-2030)
  • Table 267. Europe Infection Control, by Country USD Million (2025-2030)
  • Table 268. Europe Infection Control, by Type USD Million (2025-2030)
  • Table 269. Europe Infection Control, by Application USD Million (2025-2030)
  • Table 270. Europe Infection Control, by Sterilization USD Million (2025-2030)
  • Table 271. Europe Infection Control, by Disinfection USD Million (2025-2030)
  • Table 272. Europe Infection Control, by End User USD Million (2025-2030)
  • Table 273. Germany Infection Control, by Type USD Million (2025-2030)
  • Table 274. Germany Infection Control, by Application USD Million (2025-2030)
  • Table 275. Germany Infection Control, by Sterilization USD Million (2025-2030)
  • Table 276. Germany Infection Control, by Disinfection USD Million (2025-2030)
  • Table 277. Germany Infection Control, by End User USD Million (2025-2030)
  • Table 278. France Infection Control, by Type USD Million (2025-2030)
  • Table 279. France Infection Control, by Application USD Million (2025-2030)
  • Table 280. France Infection Control, by Sterilization USD Million (2025-2030)
  • Table 281. France Infection Control, by Disinfection USD Million (2025-2030)
  • Table 282. France Infection Control, by End User USD Million (2025-2030)
  • Table 283. Italy Infection Control, by Type USD Million (2025-2030)
  • Table 284. Italy Infection Control, by Application USD Million (2025-2030)
  • Table 285. Italy Infection Control, by Sterilization USD Million (2025-2030)
  • Table 286. Italy Infection Control, by Disinfection USD Million (2025-2030)
  • Table 287. Italy Infection Control, by End User USD Million (2025-2030)
  • Table 288. United Kingdom Infection Control, by Type USD Million (2025-2030)
  • Table 289. United Kingdom Infection Control, by Application USD Million (2025-2030)
  • Table 290. United Kingdom Infection Control, by Sterilization USD Million (2025-2030)
  • Table 291. United Kingdom Infection Control, by Disinfection USD Million (2025-2030)
  • Table 292. United Kingdom Infection Control, by End User USD Million (2025-2030)
  • Table 293. Netherlands Infection Control, by Type USD Million (2025-2030)
  • Table 294. Netherlands Infection Control, by Application USD Million (2025-2030)
  • Table 295. Netherlands Infection Control, by Sterilization USD Million (2025-2030)
  • Table 296. Netherlands Infection Control, by Disinfection USD Million (2025-2030)
  • Table 297. Netherlands Infection Control, by End User USD Million (2025-2030)
  • Table 298. Rest of Europe Infection Control, by Type USD Million (2025-2030)
  • Table 299. Rest of Europe Infection Control, by Application USD Million (2025-2030)
  • Table 300. Rest of Europe Infection Control, by Sterilization USD Million (2025-2030)
  • Table 301. Rest of Europe Infection Control, by Disinfection USD Million (2025-2030)
  • Table 302. Rest of Europe Infection Control, by End User USD Million (2025-2030)
  • Table 303. MEA Infection Control, by Country USD Million (2025-2030)
  • Table 304. MEA Infection Control, by Type USD Million (2025-2030)
  • Table 305. MEA Infection Control, by Application USD Million (2025-2030)
  • Table 306. MEA Infection Control, by Sterilization USD Million (2025-2030)
  • Table 307. MEA Infection Control, by Disinfection USD Million (2025-2030)
  • Table 308. MEA Infection Control, by End User USD Million (2025-2030)
  • Table 309. Middle East Infection Control, by Type USD Million (2025-2030)
  • Table 310. Middle East Infection Control, by Application USD Million (2025-2030)
  • Table 311. Middle East Infection Control, by Sterilization USD Million (2025-2030)
  • Table 312. Middle East Infection Control, by Disinfection USD Million (2025-2030)
  • Table 313. Middle East Infection Control, by End User USD Million (2025-2030)
  • Table 314. Africa Infection Control, by Type USD Million (2025-2030)
  • Table 315. Africa Infection Control, by Application USD Million (2025-2030)
  • Table 316. Africa Infection Control, by Sterilization USD Million (2025-2030)
  • Table 317. Africa Infection Control, by Disinfection USD Million (2025-2030)
  • Table 318. Africa Infection Control, by End User USD Million (2025-2030)
  • Table 319. North America Infection Control, by Country USD Million (2025-2030)
  • Table 320. North America Infection Control, by Type USD Million (2025-2030)
  • Table 321. North America Infection Control, by Application USD Million (2025-2030)
  • Table 322. North America Infection Control, by Sterilization USD Million (2025-2030)
  • Table 323. North America Infection Control, by Disinfection USD Million (2025-2030)
  • Table 324. North America Infection Control, by End User USD Million (2025-2030)
  • Table 325. United States Infection Control, by Type USD Million (2025-2030)
  • Table 326. United States Infection Control, by Application USD Million (2025-2030)
  • Table 327. United States Infection Control, by Sterilization USD Million (2025-2030)
  • Table 328. United States Infection Control, by Disinfection USD Million (2025-2030)
  • Table 329. United States Infection Control, by End User USD Million (2025-2030)
  • Table 330. Canada Infection Control, by Type USD Million (2025-2030)
  • Table 331. Canada Infection Control, by Application USD Million (2025-2030)
  • Table 332. Canada Infection Control, by Sterilization USD Million (2025-2030)
  • Table 333. Canada Infection Control, by Disinfection USD Million (2025-2030)
  • Table 334. Canada Infection Control, by End User USD Million (2025-2030)
  • Table 335. Mexico Infection Control, by Type USD Million (2025-2030)
  • Table 336. Mexico Infection Control, by Application USD Million (2025-2030)
  • Table 337. Mexico Infection Control, by Sterilization USD Million (2025-2030)
  • Table 338. Mexico Infection Control, by Disinfection USD Million (2025-2030)
  • Table 339. Mexico Infection Control, by End User USD Million (2025-2030)
  • Table 340. Research Programs/Design for This Report
  • Table 341. Key Data Information from Secondary Sources
  • Table 342. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Infection Control: by Type USD Million (2018-2023)
  • Figure 5. Global Infection Control: by Application USD Million (2018-2023)
  • Figure 6. Global Infection Control: by Sterilization USD Million (2018-2023)
  • Figure 7. Global Infection Control: by Disinfection USD Million (2018-2023)
  • Figure 8. Global Infection Control: by End User USD Million (2018-2023)
  • Figure 9. South America Infection Control Share (%), by Country
  • Figure 10. Asia Pacific Infection Control Share (%), by Country
  • Figure 11. Europe Infection Control Share (%), by Country
  • Figure 12. MEA Infection Control Share (%), by Country
  • Figure 13. North America Infection Control Share (%), by Country
  • Figure 14. Global Infection Control share by Players 2023 (%)
  • Figure 15. Global Infection Control share by Players (Top 3) 2023(%)
  • Figure 16. Global Infection Control share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Steris (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 19. Steris (United Kingdom) Revenue: by Geography 2023
  • Figure 20. Getinge (Sweden) Revenue, Net Income and Gross profit
  • Figure 21. Getinge (Sweden) Revenue: by Geography 2023
  • Figure 22. Ecolab (United States) Revenue, Net Income and Gross profit
  • Figure 23. Ecolab (United States) Revenue: by Geography 2023
  • Figure 24. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 25. 3M (United States) Revenue: by Geography 2023
  • Figure 26. Advanced Sterilization Products (United States) Revenue, Net Income and Gross profit
  • Figure 27. Advanced Sterilization Products (United States) Revenue: by Geography 2023
  • Figure 28. Cantel Medical (United States) Revenue, Net Income and Gross profit
  • Figure 29. Cantel Medical (United States) Revenue: by Geography 2023
  • Figure 30. Sotera Health (United States) Revenue, Net Income and Gross profit
  • Figure 31. Sotera Health (United States) Revenue: by Geography 2023
  • Figure 32. MMM Group (Germany) Revenue, Net Income and Gross profit
  • Figure 33. MMM Group (Germany) Revenue: by Geography 2023
  • Figure 34. Matachana (Spain) Revenue, Net Income and Gross profit
  • Figure 35. Matachana (Spain) Revenue: by Geography 2023
  • Figure 36. Global Infection Control: by Type USD Million (2025-2030)
  • Figure 37. Global Infection Control: by Application USD Million (2025-2030)
  • Figure 38. Global Infection Control: by Sterilization USD Million (2025-2030)
  • Figure 39. Global Infection Control: by Disinfection USD Million (2025-2030)
  • Figure 40. Global Infection Control: by End User USD Million (2025-2030)
  • Figure 41. South America Infection Control Share (%), by Country
  • Figure 42. Asia Pacific Infection Control Share (%), by Country
  • Figure 43. Europe Infection Control Share (%), by Country
  • Figure 44. MEA Infection Control Share (%), by Country
  • Figure 45. North America Infection Control Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Steris (United Kingdom)
  • Getinge (Sweden)
  • Ecolab (United States)
  • 3M (United States)
  • Advanced Sterilization Products (United States)
  • Cantel Medical (United States)
  • Sotera Health (United States)
  • MMM Group (Germany)
  • Matachana (Spain)
Additional players considered in the study are as follows:
Belimed AG (Switzerland) , Pal International (United Kingdom) , Halyard Health (United States) , Metrex Research (United States) , Reckitt Benckiser (United Kingdom)
Select User Access Type

Key Highlights of Report


Mar 2024 218 Pages 86 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global and Regional Infection Control Market Quantitative research analysis
Global and Regional Infection Control Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Steris (United Kingdom), Getinge (Sweden), Ecolab (United States), 3M (United States), Advanced Sterilization Products (United States), Cantel Medical (United States), Sotera Health (United States), MMM Group (Germany) and Matachana (Spain) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Emphasis on Food Disinfection" is seen as one of major influencing trends for Infection Control Market during projected period 2023-2030.
The Infection Control market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global and Regional Infection Control Market Report?

Have a Query? Click Here

Other Related Reports

Monoclonal Antibody Based Products Comprehensive Study by Type (Murine, Chimeric, Humanized, Human), Application (Therapeutics, Diagnostics), Diseases Type (Non-communicable Diseases, Infectious Dise...
$ 3800
Disposable Cuvettes Comprehensive Study by Type (Polystyrene, Methacrylate), Capacity (Below 10 ml, 10-20 ml, Above 20 ml), End Use (Chemical, Healthcare & Medical, Food Sector, Environmental Protect...
$ 3450
Neuromodulation Devices Comprehensive Study by Type (Internal Neuromodulation, External Neuromodulation), Application (Depression, Parkinsons Disease, Tremor, Others), End Users (Hospitals, Clinics, ...
$ 3450
Orthobiologics Comprehensive Study by Type (Viscosupplementation Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP, BMAC), Application (Fracture Recovery, Spinal Fusion, Soft Tissue Injur...
$ 3450
Maca Extract Comprehensive Study by Type (Raw, Gelatinized), Application (Health Drugs, Healthy Foods, Nutritional Supplements, Others), Uses (Leukemia, Chronic Fatigue Syndrome (CFS), Improving Ener...
$ 3750
Medical Tubing Comprehensive Study by Type (Polyvinyl Chloride (PVC), Thermoplastic Elastomer (TPE), Thermoplastic Polyurethane (TPU), Polyolefin, Silicone, Others), Application (Catheters & Cannulas...
$ 3750